Identification of Sociodemographic and Clinical Factors Influencing the Feeling of Stigmatization in People with Type 1 Diabetes.
clinical factors
sociodemographic factors
stigmatization
type 1 diabetes
Journal
Healthcare (Basel, Switzerland)
ISSN: 2227-9032
Titre abrégé: Healthcare (Basel)
Pays: Switzerland
ID NLM: 101666525
Informations de publication
Date de publication:
02 Aug 2023
02 Aug 2023
Historique:
received:
21
06
2023
revised:
28
07
2023
accepted:
31
07
2023
medline:
12
8
2023
pubmed:
12
8
2023
entrez:
12
8
2023
Statut:
epublish
Résumé
A large percentage of people with type 1 diabetes experience stigma, which may directly affect diabetes management. Moreover, it may adversely influence the acceptance of the disease and, thus, the treatment process, including compliance with medical and dietary recommendations. Therefore, it is important to seek adequate forms of counteracting the phenomenon of stigmatization. Thus, the aim of the study was to determine the factors influencing the level of perceived stigma by T1D patients, with particular emphasis on sociodemographic factors (including sex, place of residence, and education) and clinical factors related to the course of the disease. An observational cross-sectional online questionnaire was conducted in a group of 339 people with T1D. The link to the questionnaire was shared via social media. The DSAS-1 questionnaire translated into Polish was used as the research tool. A moderate level of stigmatization was found (49.78 ± 14.54 points). It was significantly lower in people living in small towns compared to rural residents (ß = -0.121, Due to the occurrence of stigma among people with T1D, which can directly affect the management of diabetes, effective and comprehensive efforts should be made to provide support to people with diabetes. It is also necessary to raise awareness among the general public and disseminate knowledge about diabetes, which can reduce stigmatization as a result. Anti-stigma messages should be included in the prevention programs about the potential side effects and risks associated with mistreating people with T1D.
Sections du résumé
BACKGROUND
BACKGROUND
A large percentage of people with type 1 diabetes experience stigma, which may directly affect diabetes management. Moreover, it may adversely influence the acceptance of the disease and, thus, the treatment process, including compliance with medical and dietary recommendations. Therefore, it is important to seek adequate forms of counteracting the phenomenon of stigmatization. Thus, the aim of the study was to determine the factors influencing the level of perceived stigma by T1D patients, with particular emphasis on sociodemographic factors (including sex, place of residence, and education) and clinical factors related to the course of the disease.
METHODS
METHODS
An observational cross-sectional online questionnaire was conducted in a group of 339 people with T1D. The link to the questionnaire was shared via social media. The DSAS-1 questionnaire translated into Polish was used as the research tool.
RESULTS
RESULTS
A moderate level of stigmatization was found (49.78 ± 14.54 points). It was significantly lower in people living in small towns compared to rural residents (ß = -0.121,
CONCLUSIONS
CONCLUSIONS
Due to the occurrence of stigma among people with T1D, which can directly affect the management of diabetes, effective and comprehensive efforts should be made to provide support to people with diabetes. It is also necessary to raise awareness among the general public and disseminate knowledge about diabetes, which can reduce stigmatization as a result. Anti-stigma messages should be included in the prevention programs about the potential side effects and risks associated with mistreating people with T1D.
Identifiants
pubmed: 37570425
pii: healthcare11152185
doi: 10.3390/healthcare11152185
pmc: PMC10418912
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Qual Life Res. 2009 Feb;18(1):23-32
pubmed: 19039679
Yonago Acta Med. 2017 Sep 15;60(3):167-173
pubmed: 28959127
BMJ Open. 2013 Nov 18;3(11):e003384
pubmed: 24247325
Scand J Public Health. 2020 Dec;48(8):855-861
pubmed: 32338563
Cent Eur J Public Health. 2018 Jun;26(2):104-110
pubmed: 30102498
Diabetes Care. 2008 Dec;31(12):2383-90
pubmed: 19033418
J Diabetes Metab Disord. 2021 Sep 08;20(2):1505-1511
pubmed: 34900802
J Clin Nurs. 2014 Oct;23(19-20):2919-27
pubmed: 24443789
Diabetes Care. 2023 Apr 1;46(4):811-818
pubmed: 36883290
Diabetes Care. 2004 May;27(5):1066-70
pubmed: 15111522
Pediatrics. 2019 Jun;143(6):
pubmed: 31043453
Diabet Med. 2017 Dec;34(12):1773-1782
pubmed: 28891210
Diabet Med. 2020 Mar;37(3):393-400
pubmed: 31638279
Int J Infect Dis. 2010 Oct;14(10):e881-7
pubmed: 20675172
Diabetes Technol Ther. 2021 Aug;23(8):577-585
pubmed: 33794101
Clin Diabetes. 2017 Jan;35(1):27-34
pubmed: 28144043
Health Soc Care Community. 2017 Sep;25(5):1620-1633
pubmed: 27489251
J Pers Soc Psychol. 2006 May;90(5):751-83
pubmed: 16737372
Adv Exp Med Biol. 2017;988:261-270
pubmed: 28971405
Front Psychol. 2020 Jun 03;11:1151
pubmed: 32581957
BMJ Open. 2021 Dec 30;11(12):e055013
pubmed: 35380981
Singapore Med J. 2011 Nov;52(11):801-9
pubmed: 22173249
J Health Care Poor Underserved. 2011 Aug;22(3):756-71
pubmed: 21841277
Diabetes Care. 2020 Nov;43(11):2651-2659
pubmed: 32887706
Front Psychol. 2021 Jul 09;12:692573
pubmed: 34305751
Int Health. 2016 Mar;8 Suppl 1:i53-70
pubmed: 26940310
Annu Rev Psychol. 2005;56:393-421
pubmed: 15709941
Patient. 2013;6(1):1-10
pubmed: 23322536
PEC Innov. 2022 Nov 28;2:100112
pubmed: 37214517
BMJ Open. 2017 Mar 29;7(3):e013425
pubmed: 28360238
J Behav Med. 2019 Jun;42(3):452-460
pubmed: 30474805
J Educ Health Promot. 2013 Oct 30;2:62
pubmed: 24520558